143 related articles for article (PubMed ID: 29228546)
1. Synthetic human leukemia models: towards precision medicine.
Cellot S; Wilhelm BT; Barabé F
Oncotarget; 2017 Nov; 8(57):96480-96481. PubMed ID: 29228546
[No Abstract] [Full Text] [Related]
2. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia.
Francis OL; Milford TA; Beldiman C; Payne KJ
J Investig Med; 2016 Mar; 64(3):740-4. PubMed ID: 26912005
[TBL] [Abstract][Full Text] [Related]
4. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators.
Wiemels JL; Pagnamenta A; Taylor GM; Eden OB; Alexander FE; Greaves MF
Cancer Res; 1999 Aug; 59(16):4095-9. PubMed ID: 10463613
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.
Fazzina R; Lombardini L; Mezzanotte L; Roda A; Hrelia P; Pession A; Tonelli R
Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135
[TBL] [Abstract][Full Text] [Related]
6. Genetics and epigenetics of pediatric leukemia in the era of precision medicine.
Ramos KN; Ramos IN; Zeng Y; Ramos KS
F1000Res; 2018; 7():. PubMed ID: 30079227
[TBL] [Abstract][Full Text] [Related]
7. Common mechanism for oncogenic activation of MLL by forkhead family proteins.
So CW; Cleary ML
Blood; 2003 Jan; 101(2):633-9. PubMed ID: 12393557
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1.
Kim SC; Hahn JS; Min YH; Yoo NC; Ko YW; Lee WJ
Blood; 1999 Jun; 93(11):3893-9. PubMed ID: 10339498
[TBL] [Abstract][Full Text] [Related]
9. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
[TBL] [Abstract][Full Text] [Related]
10. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).
Bene MC; Bernier M; Casasnovas RO; Castoldi G; Knapp W; Lanza F; Ludwig WD; Matutes E; Orfao A; Sperling C; van't Veer MB
Blood; 1998 Jul; 92(2):596-9. PubMed ID: 9657760
[TBL] [Abstract][Full Text] [Related]
11. MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.
Winters AC; Bernt KM
Front Pediatr; 2017; 5():4. PubMed ID: 28232907
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia.
Wiemels JL; Smith RN; Taylor GM; Eden OB; Alexander FE; Greaves MF;
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4004-9. PubMed ID: 11274424
[TBL] [Abstract][Full Text] [Related]
13. Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
Bertuccio SN; Leardini D; Messelodi D; Anselmi L; Manente F; Ragni F; Serravalle S; Masetti R; Pession A
Cells; 2022 Jan; 11(3):. PubMed ID: 35159287
[TBL] [Abstract][Full Text] [Related]
14. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
Takita J
Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells.
Jeong J; Jager A; Domizi P; Pavel-Dinu M; Gojenola L; Iwasaki M; Wei MC; Pan F; Zehnder JL; Porteus MH; Davis KL; Cleary ML
Blood Adv; 2019 Oct; 3(19):2825-2835. PubMed ID: 31582391
[TBL] [Abstract][Full Text] [Related]
16. Activation mechanism of the N-ras oncogene in human leukemias detected by synthetic oligonucleotide probes.
Nishida J; Hirai H; Takaku F
Biochem Biophys Res Commun; 1987 Sep; 147(2):870-5. PubMed ID: 3477229
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.
Lilljebjörn H; Orsmark-Pietras C; Mitelman F; Hagström-Andersson A; Fioretos T
Semin Cancer Biol; 2022 Sep; 84():40-49. PubMed ID: 34606984
[TBL] [Abstract][Full Text] [Related]
18. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.
Pikman Y; Tasian SK; Sulis ML; Stevenson K; Blonquist TM; Apsel Winger B; Cooper TM; Pauly M; Maloney KW; Burke MJ; Brown PA; Gossai N; McNeer JL; Shukla NN; Cole PD; Kahn JM; Chen J; Barth MJ; Magee JA; Gennarini L; Adhav AA; Clinton CM; Ocasio-Martinez N; Gotti G; Li Y; Lin S; Imamovic A; Tognon CE; Patel T; Faust HL; Contreras CF; Cremer A; Cortopassi WA; Garrido Ruiz D; Jacobson MP; Dharia NV; Su A; Robichaud AL; Saur Conway A; Tarlock K; Stieglitz E; Place AE; Puissant A; Hunger SP; Kim AS; Lindeman NI; Gore L; Janeway KA; Silverman LB; Tyner JW; Harris MH; Loh ML; Stegmaier K
Cancer Discov; 2021 Jun; 11(6):1424-1439. PubMed ID: 33563661
[TBL] [Abstract][Full Text] [Related]
19. Xenograft models for the preclinical evaluation of new therapies in acute leukemia.
Lee EM; Bachmann PS; Lock RB
Leuk Lymphoma; 2007 Apr; 48(4):659-68. PubMed ID: 17454623
[TBL] [Abstract][Full Text] [Related]
20. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
